Shares of Akorn (NASDAQ: AKRX), a generic drug manufacturer, are getting beaten down following a hint that an acquisition announced last April simply won't happen. The news has pressured Akorn's stock ...

"A barbecue that will change your life." ...

Akorn has recalled all the drugs sold under its brand or sold under other brands. DAVID J. NEAL dneal@miamiherald.com Check any prescription or over-the-counter drugs taken by you or your pets. If any ...

Add Yahoo as a preferred source to see more of our stories on Google. BERLIN (Reuters) - German healthcare group Fresenius SE (FREG.DE) said it had decided to pull out of its planned acquisition of ...

Akorn (AKRX) expects to benefit from the sales of 12 new products including isotretinoin, dronabinol, and phenylephrine ophthalmic solution. The company launched these products in 2015. New product ...

Akorn, an Illinois-based pharmaceutical company, has agreed to pay $7.9 million to resolve allegations that it caused Medicare to pay false claims, according to the U.S. Department of Justice.

Drugmaker Akorn has agreed to settle a class action lawsuit filed earlier this year that alleged the company misled investors. Akorn, headquartered in Lake Forest, valued the settlement at $74 million ...

Akorn CEO Douglas Boothe was given the task of turning the generics company around after its $4.3 billion buyout deal with Fresenius was snatched off the table. But the clock is ticking for Boothe and ...

WILMINGTON, Del (Reuters) - Akorn Inc said late on Friday its Chief Executive Officer would retire following the drugmaker's inability to salvage its takeover deal with Germany's Fresenius SE. The ...

It has been about a month since a U.S. drugmaker closed all operations, and since then, at least 14 drugs have gone into shortage and four are discontinued. 1971: Akorn Operating Co. was founded as a ...